Tenofovir Af + Emtricitabine + Bictegravir Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: Bictegravir-50 mg + Emtricitabine-200 mg + TAF-25 mg
Reference Brands: Biktarvy(EU & US)
Category: Anti Viral
Biktarvy is a once-daily, complete HIV-1 treatment with Bictegravir, Emtricitabine, and TAF. FDA and EMA approved, it offers high resistance protection and improved kidney and bone safety—no booster required.
Product Description:
Biktarvy is a complete, once-daily antiretroviral therapy for HIV-1 infection, combining Bictegravir 50 mg, Emtricitabine 200 mg, and Tenofovir Alafenamide (TAF) 25 mg in a single tablet. Approved by both the FDA and EMA, Biktarvy is indicated for adults and pediatric patients (≥2 years, ≥14 kg) who are treatment-naïve or virologically suppressed. Bictegravir, a potent integrase inhibitor, offers a high barrier to resistance and does not require boosting agents. TAF enhances renal and bone safety over older TDF-based regimens. Biktarvy simplifies HIV management, supporting long-term viral suppression and patient adherence through convenient once-daily dosing, with or without food.
Tenofovir Af + Emtricitabine + Bictegravir — third party manufacturing & bulk supply
Tenofovir Af + Emtricitabine + Bictegravir is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Tenofovir Af + Emtricitabine + Bictegravir listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Tenofovir Af + Emtricitabine + Bictegrav... →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Tenofovir alafenamide + emtricitabine + bictegravir is used for the treatment of HIV-1 infection. It helps suppress viral replication, increases CD4 counts, and maintains long-term viral control as a complete once-daily regimen.
It is made from the active ingredients tenofovir alafenamide (TAF), emtricitabine, and bictegravir. TAF and emtricitabine are nucleoside reverse transcriptase inhibitors, while bictegravir is an integrase strand transfer inhibitor.
The main trade name is Biktarvy in the USA, EU, and UK.
Biktarvy is manufactured by Gilead Sciences.
The generic name is tenofovir alafenamide + emtricitabine + bictegravir.
The primary brand name is Biktarvy.
It is manufactured by Gilead Sciences in the USA and EU, along with approved global manufacturing partners.
Related Products
Brincidofovir
Strength:
100 mg, 10 mg/ml
Form: Tablets / Oral suspension
Reference Brands: Tembexa (USA/EU)
View Details
Lenacapavir
Strength:
300 mg, 463.5 mg/1.5 mL
Form: Tablet / Injection
Reference Brands: Yeztugo (USA), Sunlenca (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
